A randomized placebo-controlled trial of convalescent plasma for adults hospitalized with COVID-19 pneumonia

Passive immunotherapy with convalescent plasma may be the only available agent during the early phases of a pandemic. Here, we report safety and efficacy of high-titer convalescent plasma for COVID-19 pneumonia. Double-blinded randomized multicenter placebo-controlled trial of adult patients hospita...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorlacius-Ussing, Louise, Brooks, Patrick Terrence, Nielsen, Henrik, Jensen, Bitten Aagaard, Wiese, Lothar, Sækmose, Susanne Gjørup, Johnsen, Stine, Gybel-Brask, Mikkel, Johansen, Isik S., Bruun, Mie Topholm, Stærke, Nina Breinholdt, Østergaard, Lars, Erikstrup, Christian, Ostrowski, Sisse Rye, Homburg, Keld Mikkelsen, Georgsen, Jørgen, Mikkelsen, Susan, Sandholdt, Håkon, Leding, Cæcilie, Hovmand, Nichlas, Clausen, Clara Lundetoft, Tinggaard, Michaela, Pedersen, Karen Brorup Heje, Iversen, Katrine Kjær, Tingsgård, Sandra, Israelsen, Simone Bastrup, Benfield, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523654/
https://www.ncbi.nlm.nih.gov/pubmed/36180450
http://dx.doi.org/10.1038/s41598-022-19629-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523654/
https://www.ncbi.nlm.nih.gov/pubmed/36180450
http://dx.doi.org/10.1038/s41598-022-19629-z

Ejemplares similares